2022/0031(COD) EU Digital COVID Certificate - Union citizens
Progress: Awaiting Parliament's position in 1st reading
| Role | Committee | Rapporteur | Shadows |
|---|---|---|---|
| Lead | LIBE |
LÓPEZ AGUILAR Juan Fernando ( S&D)
|
LENAERS Jeroen ( EPP),
IN 'T VELD Sophia ( Renew),
STRIK Tineke ( Verts/ALE),
TARDINO Annalisa ( ID),
ROOKEN Rob ( ECR),
ERNST Cornelia ( GUE/NGL)
|
| Committee Opinion | ENVI |
CANFIN Pascal ( Renew)
|
|
| Committee Opinion | TRAN |
BAUZÁ DÍAZ José Ramón ( Renew)
|
Cláudia MONTEIRO DE AGUIAR ( PPE),
István UJHELYI ( S&D),
Anne-Sophie PELLETIER ( GUE/NGL)
|
Events
2022/04/05
EP - Committee opinion
Documents
2022/03/18
EP - Committee draft report
Documents
2022/03/17
EP - CANFIN Pascal (Renew) appointed as rapporteur in ENVI
2022/03/16
EP - LÓPEZ AGUILAR Juan Fernando (S&D) appointed as rapporteur in LIBE
2022/03/07
EP - BAUZÁ DÍAZ José Ramón (Renew) appointed as rapporteur in TRAN
2022/02/14
EP - Committee referral announced in Parliament, 1st reading
2022/02/03
EC - Legislative proposal
Details
PURPOSE: to extend the application of Regulation (EU) 2021/953 on a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (EU Digital COVID Certificate) to facilitate free movement during the COVID-19 pandemic.
PROPOSED ACT: Regulation of the European Parliament and of the Council.
ROLE OF THE EUROPEAN PARLIAMENT: the European Parliament decides in accordance with the ordinary legislative procedure and on an equal footing with the Council.
BACKGROUND: since the adoption of Regulation (EU) 2021/953 , the epidemiological situation with regard to the COVID-19 pandemic has evolved considerably. On the one hand, by 31 January 2022, more than 80% of the adult population in the Union had completed their primary vaccination cycle, and more than 50% have received a booster dose, despite significant differences between Member States. Increasing vaccine uptake remains a crucial objective in the fight against the pandemic, given the protection against hospitalisation and severe disease afforded by vaccination, and thus plays an important role in ensuring that restrictions to the free movement of persons can be lifted.
After a peak in Omicron cases, a high proportion of the population is expected to enjoy, at least for a certain period, protection from COVID-19 either due to vaccination or prior infection, or both. However, it is not possible to predict the impact of a possible increase in infections in the second half of 2022. In addition, the possibility of a worsening of the pandemic situation because of the emergence of new SARS-CoV-2 variants of concern cannot be ruled out.
In view of the above, it cannot be excluded that Member States continue to require Union citizens exercising their right to free movement to present proof of COVID-19 vaccination, test or recovery beyond 30 June 2022 , that is, the date when Regulation (EU) 2021/953 is currently set to expire. It is important to ensure that Union citizens and their family members are not deprived of the possibility to make use of their EU Digital COVID Certificates, which are an effective, secure and privacy-preserving way of proving one’s COVID-19 status, in the event that certain restrictions to free movement based on public health are still in place after 30 June 2022.
CONTENT: under this proposal, the Commission is proposing to extend, by 12 months ( until 30 June 2023 ), the application of Regulation (EU) 2021/953, which lays down a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (EU Digital COVID Certificate) for the purpose of facilitating the holders’ exercise of their right to free movement during the COVID-19 pandemic. This should allow EU citizens and their family members exercising their right to free movement to continue demonstrating that they fulfil public health requirements imposed, in compliance with EU law, by the Member State of destination.
In addition to the extension of the EU Digital COVID Certificate Regulation until June 2023, the Commission also proposes some limited amendments to Regulation (EU) 2021/953 such as:
- a broadening of the definition of SARS-CoV-2 tests that rely on the detection of viral proteins (antigens) to include antigenic assays performed in a laboratory setting and not only rapid antigen tests that give results in less than 30 minutes;
- an explicit clarification that vaccination certificates are to contain the number of doses administered to the holder, regardless of the Member State in which they have been administered, to make sure that the overall number actually administered is accurately reflected;
- a clarification that EU Digital COVID Certificates may also be issued to persons participating in clinical trials for COVID-19 vaccines, and that such certificates may be accepted by other Member States in order to waive restrictions to free movement;
- an extension by 12 months of the period of application set out in Regulation (EU) 2021/953, as well as of the power to adopt delegated acts with a view to adapting the information included in the vaccination certificate.
The proposal notes that the domestic use of EU Digital COVID Certificates remains a matter for Member States to decide. The EU legislation on the EU Digital COVID Certificate neither prescribes nor prohibits the domestic use of EU Digital COVID Certificate (such as for access to events or restaurants). At the same time, where a Member State establishes a system of COVID-19 certificate for domestic purposes, it should continue to ensure that the EU Digital COVID Certificate is also fully accepted for those purposes.
Beyond that, the Commission also encourages Member States to align their domestic validity periods with the validity period set at EU level for the purpose of travel.
Documents
Documents
- Committee opinion: PE730.193
- Committee draft report: PE729.924
- Legislative proposal: COM(2022)0050
- Legislative proposal: EUR-Lex
- Legislative proposal: COM(2022)0050 EUR-Lex
- Committee draft report: PE729.924
- Committee opinion: PE730.193
Activities
- Dita CHARANZOVÁ
- Juan Fernando LÓPEZ AGUILAR
Plenary Speeches (0)
- Jean-Paul GARRAUD
Plenary Speeches (0)
Votes
Certificat COVID numérique de l’UE - citoyens de l'Union - EU Digital COVID Certificate - Union citizens - Digitales COVID-Zertifikat der EU – Unionsbürger - A9-0138/2022 - Juan Fernando López Aguilar - Décision d'engager des négociations interinstitutionnelles #
2022/05/05 Outcome: +: 432, -: 130, 0: 23
The Left
NI| Amendments | Dossier |
| 103 |
2022/0031(COD)
2022/03/21
TRAN
25 amendments...
Amendment 10 #
Proposal for a regulation Recital 8 (8) As a result, it cannot be excluded that Member States continue to require Union citizens exercising their right to free movement to present proof of COVID-19 vaccination, test or recovery beyond 30 June 2022, the date when Regulation (EU) 2021/953 is set to expire. It is thus important to avoid that, in the event that certain restrictions to free movement based on public health are still in place after 30 June 2022, Union citizens and their family members are deprived of the possibility to make use of their EU Digital COVID Certificates, which are an effective, secure and privacy-preserving way of proving one’s COVID-19 status. At the same time, given that any restrictions to the free movement of persons within the Union put in place to limit the spread of SARS-CoV- 2, including the requirement to present EU Digital COVID Certificates, should be lifted as soon as the epidemiological situation allows, the extension of the application of Regulation (EU) 2021/953 should be limited to 12 months. In addition, the extension of that Regulation should not be understood as requiring Member States, in particular those that lift domestic public health measures, to maintain or impose free movement restrictions. In addition, any need for verification of certificates established by Regulation (EU) 2021/953 should not be considered to justify the temporary reintroduction of controls at internal borders. The power to adopt acts in accordance with Article 290 of the Treaty on the Functioning of the European Union delegated to the Commission pursuant to Regulation (EU) 2021/953 should be
Amendment 11 #
Proposal for a regulation Recital 8 (8) As a result, it cannot be excluded that Member States continue to require Union citizens exercising their right to free movement to present proof of COVID-19 vaccination, test or recovery beyond 30 June 2022, the date when Regulation (EU) 2021/953 is set to expire. It is thus important to avoid that, in the event that certain restrictions to free movement based on public health are still in place after 30 June 2022, Union citizens and their family members are deprived of the possibility to make use of their EU Digital COVID Certificates, which are an effective, secure and privacy-preserving way of proving one’s COVID-19 status. At the same time, given that any restrictions to the free movement of persons within the Union put in place to limit the spread of SARS-CoV- 2, including the requirement to present EU Digital COVID Certificates, should be lifted as soon as the epidemiological
Amendment 12 #
Proposal for a regulation Recital 8 (8) As a result, it cannot be excluded that Member States continue to require Union citizens exercising their right to free movement to present proof of COVID-19 vaccination, test or recovery beyond 30 June 2022, the date when Regulation (EU) 2021/953 is set to expire. It is thus important to avoid that, in the event that certain restrictions to free movement based on public health are still in place after 30 June 2022, Union citizens and their family members are deprived of the possibility to make use of their EU Digital COVID Certificates, which are an effective, secure and privacy-preserving way of proving one’s COVID-19 status. At the same time, given that any restrictions to the free movement of persons within the Union put in place to limit the spread of SARS-CoV-
Amendment 13 #
Proposal for a regulation Recital 8 a (new) (8a) The EU Digital COVID Certificate (EUDCC) system has proven to be the only functioning COVID-19 certificate system operational at the international level on a large scale. As a result, EUDCC has gained increasing global significance and contributed to addressing the pandemic at the international level, by facilitating safe international travel and economic recovery. By 25 February 2022, 35 non-EU countries and territories are connected to the EUDCC system, with more expected to join in the future. Nevertheless, Regulation (EU) 2021/953 only obliges Member States to accept the EU Digital COVID Certificates issued for vaccines that have been granted a marketing authorisation by the European Medicines Agency. It does not, therefore, include most of the vaccines that are currently administered around the world, including those that have completed the WHO emergency use listing procedure. This undermines the role of the EUDCC system as one of the key digital solutions to restore international mobility and the de-facto global standard. Many of the vaccines that have completed the WHO Emergency Use Listing procedure have not applied, and are unlikely to do so in the future, for marketing authorisation to EMA or a competent Member State authority simply because the developers do not intend to put those vaccines on the EU market. In many cases, the same vaccines administered around the EU and listed by Regulation (EU) 2021/953 are available under a different trade name in other countries, and therefore fall out of the scope of this Regulation. This also applies to some of the vaccines that the EU is helping deliver under the COVAX scheme.
Amendment 14 #
Proposal for a regulation Recital 8 a (new) (8a) Several Member States have used the EU Digital COVID Certificate for domestic purposes by implementing national measures to allow or ban access to bars, restaurants, hotels, concert halls and other venues, despite the fact that the initial aim of the EU Digital COVID Certificate was not to be used for these purposes and that non-discrimination to access to essential services should have been preserved. Therefore, without prejudice to Member States’ competence to impose national restrictions on grounds of public health and taking into account the current phase of the pandemic, the EU Digital COVID Certificate should serve its original and primary objective, namely to be used as a tool to facilitate free of movement and EU level coordination. The EU Digital COVID Certificate should not be understood as a measure for Member States to impose unjustified and disproportionate restrictions for domestic purposes.
Amendment 15 #
Proposal for a regulation Recital 9 a (new) (9a) The EU Digital COVID Certificate (EUDCC) system has proven to be the only functioning COVID-19 certificate system operational at the international level on a large scale. As a result, EUDCC has gained increasing global significance and contributed to addressing the pandemic at the international level, by facilitating safe international travel and economic recovery. By 25 February 2022, 35 non-EU countries and territories are connected to the EUDCC system, with more expected to join in the future. And 1,7 billion EUDCC have been issued so far. Regulation (EU) 2021/953 only obliges Member States to accept the EU Digital COVID Certificates issued for vaccines that have been granted a marketing authorisation by the European Medicines Agency. Regulation (EU) 2021/953 does not, therefore, include most of the vaccines that are currently administered around the world, including those that have completed the WHO emergency use listing procedure. This undermines the role of the EUDCC system as one of the key digital solutions to restore international mobility and the de-facto global standard. Many of the vaccines that have completed the WHO emergency use listing procedure have not applied (and are unlikely to do so in the future) for marketing authorisation to EMA or a competent Member State authority simply because the developers do not intend to put those vaccines on the EU market. In many cases, the same vaccines administered around the EU and listed by Regulation (EU) 2021/953 are available under a different trade name in other countries, and therefore fall out of the scope of Regulation (EU) 2021/953. This also applies to some of the vaccines that the EU is helping deliver under the COVAX scheme. The limited scope of Regulation (EU) 2021/953 is also creating vaccine inequalities among EU citizens. Some Member States already administer to their citizens vaccines which are not mentioned by Regulation (EU) 2021/953. The EU Digital COVID Certificate of these EU citizens has limited or no value in other Member States. As a result, and in an effort to enlarge the scope of the vaccines that may be used as the basis for the issuance of an EU Digital COVID Certificate, the definition for vaccine should be adapted to include all vaccines that have completed the WHO emergency use listing procedure.
Amendment 16 #
Proposal for a regulation Recital 13 a (new) (13a) Considering that many Member States are using the EU Digital COVID Certificate, or some of its components to allow access to bars, restaurants, hotels, concert halls and other venues, it is important that national rules mirror border requirements. This would further support the recovery of the EU tourism sector and offer certainty for non-EU travellers. Therefore, without prejudice to Member States’ competence to impose national restrictions on grounds of public health, Member States are recommended to accept at national level all the vaccination certificates accepted at the border.
Amendment 17 #
Proposal for a regulation Recital 13 a (new) (13a) Considering that the EU Digital COVID Certificate is the basis for safe free movement and EU level coordination, it is important that it is implemented in a consistent manner in particular with regards to the rules regarding children and young adults below 18 years old.
Amendment 18 #
Proposal for a regulation Recital 13 b (new) (13b) Considering that the EU Digital COVID Certificate is the basis for safe free movement and EU level coordination, it is important that it is implemented in a consistent manner in particular with regards to the rules regarding children and young adults below 18 years old.
Amendment 19 #
Proposal for a regulation Article 1 – paragraph 1 – point 3 – point a a (new) Regulation (EU) 2021/953 Article 5 – paragraph 5 – subparagraph 1 (aa) In Article 5 paragraph 5, the first subparagraph is replaced by the following: " 5. Where Member States accept proof of vaccination in order to waive restrictions to free movement put in place, in accordance with Union law, to limit the spread of SARS-CoV-2, they shall also accept, under the same conditions, vaccination certificates issued by other Member States in accordance with this Regulation for a COVID-19 vaccines that ha
Amendment 20 #
Proposal for a regulation Article 1 – paragraph 1 – point 3 – point a a (new) Regulation (EU) 2021/953 Article 5 – paragraph 5 – subparagraph 1 (aa) In Article 5 paragraph 5, the first subparagraph is replaced by the following: "5. Where Member States accept proof
Amendment 21 #
Proposal for a regulation Article 1 – paragraph 1 – point 3 – point a b (new) Regulation (EU) 2021/953 Article 5 – paragraph 5 – subparagraph 2 (ab) In Article 5 paragraph 5, the second subparagraph is replaced by the following: "Member States may also accept, for the same purpose, vaccination certificates issued by other Member States in accordance with this Regulation for a COVID-19 vaccine that has been granted a marketing authorisation by the competent authority of a Member State pursuant to Directive 2001/83/EC, or a COVID-19 vaccine the distribution of which has been temporarily authorised pursuant to Article 5(2) of that Directive
Amendment 22 #
Proposal for a regulation Article 1 – paragraph 1 – point 3 – point b a (new) Regulation (EU) 2021/953 Article 5 – paragraph 5 – subparagraph 2 a (new) (ba) In Article 5 paragraph 5, the following subparagraph is inserted: "Where Member States accept proof of vaccination in order to waive restrictions to free movement put in place, in accordance with Union law, to limit the spread of SARS-CoV-2, they shall also accept, under the same conditions, vaccination certificates issued by other Member States where the last dose, be it during the primary vaccination series or the booster, has been administered with a vaccine that has been authorised under this Article, even if the previous dose or doses are not administered with a vaccine approved under this Article".
Amendment 23 #
Proposal for a regulation Article 1 – paragraph 1 – point 3 – point b b(new) Regulation (EU) 2021/953 Article 5 – paragraph 5 – subparagraph 2 a (new) (bb) In Article 5 paragraph 5, the following subparagraph is inserted: "Where Member States accept proof of vaccination in order to waive restrictions to free movement put in place, in accordance with Union law, to limit the spread of SARS-CoV-2, they shall also accept, under the same conditions, vaccination certificates issued by other Member States where the last dose, be it during the primary vaccination series or the booster, has been administered with a vaccine that has been authorised under this Article, even if the previous dose or doses are not administered with a vaccine approved under this Article".
Amendment 24 #
Proposal for a regulation Article 1 – paragraph 1 – point 5 a (new) Regulation (EU) 2021/953 Article 11 – paragraph 1 (5a) Article 11, paragraph 1 is replaced by the following: "1. Without prejudice to Member States’ competence to impose restrictions on grounds of public health, where Member States accept vaccination certificates, test certificates indicating a negative result or certificates of recovery, they shall refrain from imposing additional restrictions to free movement,
Amendment 25 #
Proposal for a regulation Article 1 – paragraph 1 – point 5 a (new) Regulation (EU) 2021/953 Article 11 – paragraph 1 (5a) In Article 11, paragraph 1 is replaced by the following: "1. Without prejudice to Member States’ competence to impose restrictions on grounds of public health, where Member States accept vaccination certificates, test certificates indicating a negative result or certificates of recovery, they shall refrain from imposing additional restrictions to free movement
Amendment 26 #
Proposal for a regulation Article 1 – paragraph 1 – point 5 a (new) Regulation (EU) 2021/953 Article 11 – paragraph 1 (5a) In Article 11, paragraph 1 is replaced by the following: "1. Without prejudice to Member States’ competence to impose restrictions on grounds of public health, where Member States accept vaccination
Amendment 27 #
Proposal for a regulation Article 1 – paragraph 1 – point 5 a (new) Regulation (EU) 2021/953 Article 11 – paragraph 3 Amendment 28 #
Proposal for a regulation Article 1 – paragraph 1 – point 5 b (new) Regulation (EU) 2021/953 Article 11 – paragraph 3 Amendment 29 #
Proposal for a regulation Article 1 – paragraph 1 – point 5 c (new) Regulation (EU) 2021/953 Article 11 – paragraph 3 Amendment 30 #
Proposal for a regulation Article 1 – paragraph 1 – point 5 d (new) Regulation (EU) 2021/953 Article 11 – paragraph 4 a (new) (5d) In Article 11, the following paragraph is added: "4a. Member States shall refrain from using the EU Digital COVID Certificate to introduce further restrictions for domestic purposes. "
Amendment 31 #
Proposal for a regulation Article 1 – paragraph 1 – point 6 Regulation (EU) 2021/953 Article 12 – paragraph 2 2. The power to adopt delegated acts referred to in Article 5(2), Article 6(2) and Article 7(1) and (2) shall be conferred on the Commission for a period of
Amendment 32 #
Proposal for a regulation Article 1 – paragraph 1 – point 8 Regulation (EU) 2021/953 Article 17 – paragraph 2 Amendment 33 #
Proposal for a regulation Article 1 – paragraph 1 – point 8 Regulation (EU) 2021/953 Article 17 – paragraph 2 It shall apply from 1 July 2021 to 3
Amendment 9 #
Proposal for a regulation Recital 8 (8) As a result, it cannot be excluded that Member States continue to require Union citizens exercising their right to free movement to present proof of COVID-19 vaccination, test or recovery beyond 30 June 2022, the date when Regulation (EU) 2021/953 is set to expire. It is thus important to avoid that, in the event that certain restrictions to free movement based on public health are still in place after 30 June 2022, Union citizens and their family members are deprived of the possibility to make use of their EU Digital COVID Certificates, which are an effective, secure and privacy-preserving way of proving one’s COVID-19 status. At the same time, given that any restrictions to the free movement of persons within the Union put in place to limit the spread of SARS-CoV- 2, including the requirement to present EU Digital COVID Certificates, should be lifted as soon as the epidemiological situation allows, the extension of the application of Regulation (EU) 2021/953 should be limited to 12 months. In addition, the extension of that Regulation should not be understood as requiring Member States, in particular those that lift domestic public health measures, to maintain or impose free movement restrictions. In addition, any need for verification of certificates established by Regulation (EU) 2021/953 should not be considered to justify the temporary reintroduction of controls at internal borders. The power to adopt acts in accordance with Article 290 of the Treaty on the Functioning of the European Union delegated to the Commission pursuant to Regulation (EU) 2021/953 should be equally extended. It is necessary to ensure that the EU Digital COVID Certificate system can adapt to scientific progress in containing the COVID-19 pandemic.
source: 729.947
2022/04/08
LIBE
78 amendments...
Amendment 10 #
Proposal for a regulation Recital 1 (1) Regulation (EU) 2021/953 of the European Parliament and of the Council1 lays down a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (EU Digital COVID Certificate) for the purpose of facilitating the holders’ exercise of their right to free movement during the COVID- 19 pandemic.
Amendment 11 #
Proposal for a regulation Recital 1 (1) Regulation (EU) 2021/953 of the European Parliament and of the Council1 lays down a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (EU Digital COVID Certificate) for the purpose of facilitating the holders’ exercise of their right to free movement during the COVID- 19 pandemic, even though there have been operational issues with the digital certificate that have reduced its effectiveness, particularly involving fraudulent use of secret cryptographic keys. It is also to contribute to facilitating the gradual lifting of restrictions to free movement put in place by the Member States, in accordance with Union law, to limit the spread of SARS-
Amendment 12 #
Proposal for a regulation Recital 2 (2) According to Regulation (EU) 2021/953, test certificates are to be issued based on two types of tests for SARS-CoV- 2 infection, namely molecular nucleic acid amplification tests (‘NAAT’), including those using reverse transcription polymerase chain reaction (‘RT-PCR’), and rapid antigen tests, which rely on detection of viral proteins (antigens) using a lateral flow immunoassay that gives results in less than 30 minutes, provided they are carried out by health professionals or by skilled testing personnel. However, Regulation (EU) 2021/953 does not cover antigenic assays, such as enzyme-linked immunosorbent assays or automated immunoassays, which test for antigens in a laboratory setting. As of July 2021, the technical working group on COVID-19 diagnostic tests2, responsible for preparing updates to the common list of COVID-19 rapid antigen tests3 agreed by the Health Security Committee established by Article 17 of Decision No 1082/2013/EU of the European Parliament and of the Council4, also reviews proposals put forward by Member States and manufacturers for COVID-19 laboratory- based antigenic assays. Those proposals are assessed against the same criteria as those used for rapid antigen tests, and the Health Security Committee has established a list of the laboratory-based antigenic assays that meet those criteria. As a result, and in an effort to enlarge the scope of the different types of diagnostic tests that may be used as the basis for the issuance of an EU Digital COVID Certificate, the definition for rapid antigen tests
Amendment 13 #
Proposal for a regulation Recital 2 (2) According to Regulation (EU) 2021/953, test certificates are to be issued based on two types of tests for SARS-CoV- 2 infection, namely molecular nucleic acid amplification tests (‘NAAT’), including those using reverse transcription polymerase chain reaction (‘RT-PCR’), and rapid antigen tests, which rely on detection of viral proteins (antigens) using a lateral flow immunoassay that gives
Amendment 14 #
Proposal for a regulation Recital 2 (2) According to Regulation (EU) 2021/953, test certificates are to be issued based on two types of tests for SARS-CoV- 2 infection, namely molecular nucleic acid amplification tests (‘NAAT’), including those using reverse transcription polymerase chain reaction (‘RT-PCR’), and rapid antigen tests, which rely on detection of viral proteins (antigens) using a lateral flow immunoassay that gives results in less than 30 minutes, provided they are carried out by health professionals or by skilled testing personnel. However, Regulation (EU)
Amendment 15 #
Proposal for a regulation Recital 2 (2) According to Regulation (EU) 2021/953, test certificates are to be issued based on two types of tests for SARS-CoV- 2 infection, namely molecular nucleic acid amplification tests (‘NAAT’), including those using reverse transcription polymerase chain reaction (‘RT-PCR’), and rapid antigen tests, which rely on detection of viral proteins (antigens) using a lateral flow immunoassay that gives results in less than 30 minutes, provided they are carried out by health professionals or by skilled testing personnel. However, Regulation (EU) 2021/953 does not cover antigenic assays, such as enzyme-linked immunosorbent assays or automated immunoassays, which test for antigens in a laboratory setting. As of July 2021, the
Amendment 16 #
Proposal for a regulation Recital 2 (2) According to Regulation (EU) 2021/953, test certificates are to be issued based on two types of tests for SARS-CoV- 2 infection, namely molecular nucleic acid amplification tests (‘NAAT’), including those using reverse transcription polymerase chain reaction (‘RT-PCR’), and rapid antigen tests, which rely on detection of viral proteins (antigens) using a lateral flow immunoassay that gives results in less than 30 minutes, provided they are carried out by health professionals or by skilled testing personnel. However, Regulation (EU) 2021/953 does not cover antigenic assays, such as enzyme-linked immunosorbent assays or automated immunoassays, which test for antigens in a laboratory setting. As of July 2021, the technical working group on COVID-19 diagnostic tests2, responsible for preparing updates to the common list of COVID-19 rapid antigen tests3 agreed by the Health Security Committee established by
Amendment 17 #
Proposal for a regulation Recital 2 a (new) (2a) Notes a blind spot in the application of Regulation (EU) 2021/953 regarding the validity period of the COVID certificate after the booster dose (3rd dose).
Amendment 18 #
Proposal for a regulation Recital 4 (4) In particular in light of the emergence of new SARS-CoV-2 variants of concern, the continued development and study of COVID-19 vaccines and drug treatments is a crucial aspect in the fight against the COVID-19 pandemic. In this context, it is important to facilitate the participation of volunteers in clinical trials, that is, studies performed to investigate the safety or efficacy of a medicine, such as a COVID-19 vaccine or drug treatment. Clinical research plays a fundamental role in the development of vaccines and treatments, and voluntary participation in clinical trials should therefore be encouraged. Depriving vaccine trial volunteers from access to EU Digital COVID Certificates could constitute a major disincentive to participate, delaying the conclusion of clinical trials and negatively impacting public health more generally. In addition, the integrity of clinical trials, including in terms of data blinding and confidentiality, should be preserved to ensure the validity of their
Amendment 19 #
Proposal for a regulation Recital 4 (4) In particular in light of the emergence of new SARS-CoV-2 variants of concern, the continued development and study of COVID-19 vaccines is a crucial aspect in the fight against the COVID-19 pandemic. In this context, it is important to facilitate the participation of volunteers in clinical trials, that is, studies performed to investigate the safety or efficacy of a medicine, such as a COVID-19 vaccine. Clinical research plays a fundamental role in the development of vaccines, and voluntary participation in clinical trials should therefore be encouraged. Depriving volunteers from access to EU Digital COVID Certificates could constitute a major disincentive to participate, delaying the conclusion of clinical trials and negatively impacting public health more generally. In addition, the integrity of clinical trials, including in terms of data blinding and confidentiality, should be
Amendment 20 #
Proposal for a regulation Recital 4 (4) In particular in light of the emergence of new SARS-CoV-2 variants of concern, the continued development and study of COVID-19 vaccines is a crucial aspect in the fight against the COVID-19 pandemic. In this context, it is important to facilitate the participation of volunteers in clinical trials, that is, studies performed to investigate the safety or efficacy of a medicine, such as a COVID-19 vaccine. Clinical research plays a fundamental role in the development of vaccines, and voluntary participation in clinical trials should therefore be encouraged. Depriving volunteers from access to EU Digital COVID Certificates could constitute a major disincentive to participate, delaying the conclusion of clinical trials and negatively impacting public health more generally. In addition, the integrity of
Amendment 21 #
Proposal for a regulation Recital 4 (4) In particular in light of the emergence of new SARS-CoV-2 variants of concern, the continued development and study of COVID-19 vaccines is a crucial aspect in the fight against the COVID-19 pandemic. In this context, it is important to facilitate the participation of volunteers in clinical trials, that is, studies performed to investigate the safety or efficacy of a medicine, such as a COVID-19 vaccine. Clinical research plays a fundamental role in the development of vaccines, and voluntary participation in clinical trials should therefore be encouraged. Depriving volunteers from access to EU Digital COVID Certificates could
Amendment 22 #
Proposal for a regulation Recital 4 a (new) (4a) During 2021, around 2 million Union citizens were vaccinated by COVID-19 vaccines the distribution of which has been temporarily authorised pursuant to Article 5(2) of Directive 2001/83/EC of the European Parliament and of the Council1a. The emergence of Omicron variant considerably changed vaccination policies throughout the Union. Booster vaccination became indispensable to prevent severe diseases resulting from infection. For preventing severe diseases, it is important that everyone obtains booster vaccination and those persons who, during the primary course of vaccination, did not receive vaccines authorised under Regulation (EC) No 726/2004 are also assured that all their vaccination certificates should be recognized in case a booster vaccine is authorised under that Regulation. ____________________- 1a Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ L 311, 28.11.2001, p. 67).
Amendment 23 #
Proposal for a regulation Recital 5 (5) Since the adoption of Regulation (EU) 2021/953, the epidemiological situation with regard to the COVID-19 pandemic has evolved considerably. On the one hand, by 31 January 2022, more than 80% of the adult population in the Union have completed their primary vaccination cycle, and more than 50% have received a booster dose, despite significant differences between Member States6. Increasing vaccine uptake remains a crucial objective in the fight against the pandemic, given the increased protection against hospitalisation and severe disease afforded by vaccination, and thus plays an important role in ensuring that restrictions to the free movement of persons can be lifted. It would be appropriate to review the legitimacy of the COVID Certificate in the light of the number of vaccinated people in the EU and the lower risk presented by the new variants, as restricting the free movement of persons within the Union should remain an exception. _________________ 6
Amendment 24 #
Proposal for a regulation Recital 5 (5) Since the adoption of Regulation (EU) 2021/953, the epidemiological situation with regard to the COVID-19 pandemic has
Amendment 25 #
Proposal for a regulation Recital 6 (6) On the other hand, the spread of the SARS-CoV-2 variant of concern ‘Delta’ in the second half of 2021 caused an increase in the number of infections, hospitalisation and deaths, requiring Member States to adopt strict public health measures in an effort to protect healthcare system
Amendment 26 #
Proposal for a regulation Recital 7 (7) After a peak in Omicron cases, a high proportion of the population is expected to enjoy, at least for a certain period, protection from COVID-19 either due to vaccination or prior infection, or both. However, it is not possible to predict the impact of a possible increase in infections in the second half of 2022. In addition, the possibility of a worsening of the pandemic situation because of the emergence of new SARS-CoV-2 variants of concern cannot be ruled out. As also noted by ECDC,
Amendment 27 #
Proposal for a regulation Recital 7 (7) After a peak in Omicron cases, a high proportion of the population is expected to enjoy, at least for a certain period, protection from COVID-19 either due to vaccination or prior infection, or both. However, it is not possible to predict the impact of
Amendment 28 #
Proposal for a regulation Recital 8 Amendment 29 #
Proposal for a regulation Recital 8 (8) As a result, it cannot be excluded that Member States continue to require Union citizens exercising their right to free movement to present proof of COVID-19 vaccination, test or recovery beyond 30 June 2022, the date when Regulation (EU) 2021/953 is set to expire. It is thus important to avoid that, in the event that certain restrictions to free movement based on public health are still in place after 30 June 2022, Union citizens and their family members are deprived of the possibility to make use of their EU Digital COVID
Amendment 30 #
Proposal for a regulation Recital 8 (8) As a result, it cannot be excluded that Member States continue to require Union citizens exercising their right to free movement to present proof of COVID-19 vaccination, test or recovery beyond 30 June 2022, the date when Regulation
Amendment 31 #
Proposal for a regulation Recital 8 (8) As a result, it cannot be excluded that Member States continue to require Union citizens exercising their right to free movement to present proof of COVID-19 vaccination, test or recovery beyond 30 June 2022, the date when Regulation (EU) 2021/953 is set to expire. It is thus important to avoid that, in the event that certain restrictions to free movement based on public health are still in place after 30 June 2022, Union citizens and their family members are deprived of the possibility to make use of their EU Digital COVID Certificates, which are an effective, secure
Amendment 32 #
Proposal for a regulation Recital 8 (8) As a result, it cannot be excluded that Member States continue to require Union citizens exercising their right to free movement to present proof of COVID-19 vaccination, test or recovery beyond 30 June 2022, the date when Regulation (EU) 2021/953 is set to expire. It is thus important to avoid that, in the event that certain restrictions to free movement based on public health are still in place after 30
Amendment 33 #
Proposal for a regulation Recital 8 (8) As a result, it cannot be excluded that Member States continue to require
Amendment 34 #
Proposal for a regulation Recital 8 (8) As a result, it cannot be excluded that Member States continue to require Union citizens exercising their right to free movement to present proof of COVID-19 vaccination, test or recovery beyond 30 June 2022, the date when Regulation (EU) 2021/953 is set to expire. It is thus important to avoid that, in the event that certain restrictions to free movement based on public health are still in place after 30 June 2022, Union citizens and their family members are deprived of the possibility to make use of their EU Digital COVID Certificates, which are an effective, secure and privacy-preserving way of proving one’s COVID-19 status. At the same time, given that any restrictions to the free movement of persons within the Union put in place to limit the spread of SARS-CoV- 2, including the requirement to present EU Digital COVID Certificates, should be lifted as soon as the epidemiological situation allows, the extension of the application of Regulation (EU) 2021/953 should be limited to
Amendment 35 #
Proposal for a regulation Recital 8 a (new) (8a) On 25 January 2022, the Council adopted Recommendation (EU) 2022/1071a, moving from a ‘region-based’ approach to a ‘person-based’ approach. That Recommendation provides that a person who has a valid EU Digital COVID Certificate should in principle not be subject to additional travel restrictions, such as tests or quarantine, regardless of their place of departure in the Union. Persons who are not in possession of a valid EU Digital COVID Certificate could be required to undergo a test prior to or no later than 24 hours after arrival. However, Member States do not respect that Recommendation, leading to unpredictable, unclear and difficult situations for Union citizens travelling with a valid certificate. Therefore, the Commission should establish a European COVID Barometer by way of delegated act, laying down clear and harmonised Union-wide criteria for the activation of restrictions by Member States in each stage of the barometer. That tool should offer clarity and predictability to Union citizens, as it would be clear which additional travel restrictions are allowed to be in place during each stage of the barometer. It would also lead to a higher level of compliance with COVID-19 related-measures. __________________ 1a Council Recommendation (EU) 2022/107 of 25 January 2022 on a coordinated approach to facilitate safe free movement during the COVID-19 pandemic and replacing Recommendation (EU) 2020/1475 (OJ L 18, 27.1.2022, p. 110).
Amendment 36 #
Proposal for a regulation Recital 8 b (new) (8b) The EU Digital COVID Certificate has been conceived only as a tool to facilitate free movement within the Union during the COVID-19 pandemic, taking into account the principles of proportionality and non-discrimination. However, in contravention of the objective of Regulation (EU) 2021/953, the EU Digital COVID Certificate has been used by many national, regional and local authorities in the Member States, as well as by the Union institutions, to impose restrictions for internal and domestic purposes. Without prejudice to Member States’ competence to introduce national restrictions on grounds of public health this Regulation and the EU Digital COVID Certificate should not be intended as a tool for Member States to impose unjustified, disproportionate or discriminatory restrictions for domestic purposes.
Amendment 37 #
Proposal for a regulation Recital 8 c (new) Amendment 38 #
Proposal for a regulation Recital 8 d (new) (8d) In light of the above it is necessary to continuously evaluate which measures remain effective, necessary and proportionate as regards the purpose of the fight against the COVID-19 pandemic.
Amendment 39 #
Proposal for a regulation Recital 8 e (new) (8e) Since the application of Regulation (EU) 2021/953, a large number of Member States have adopted temporary domestic measures obliging Union citizens to present a COVID-19 certificate for access to public transport, restaurants, hotels, bars, cultural institutions, sport facilities, and other spaces. Although those Member States have ensured that the EU Digital COVID Certificate is also accepted for such domestic measures, those domestic measures have led to considerable confusion among Union citizens that are willing to make use of such facilities during their stay in another Member State, and have therefore become a major obstacle to the freedom of movement of Union citizens from other Member States. Member States should therefore only adopt such domestic measures on the basis of the European COVID Barometer. This will offer clarity and predictability to Union citizens, as it would be clear which domestic measures are allowed to be in place during each stage of the barometer. It would also lead to a higher level of compliance with COVID-19 related measures.
Amendment 40 #
Proposal for a regulation Recital 8 f (new) (8f) By 31 December 2022, the Commission should submit a report to the European Parliament and Council on the application of this Regulation, including an assessment on the necessity to maintain, shorten or extend the period of application of this Regulation, taking into account the evolution of the epidemiological situation with regard to the COVID-19 pandemic.
Amendment 41 #
Proposal for a regulation Recital 11 (11) Similarly, Regulation (EU) 2022/XXXX of the European Parliament and of the Council8 does not prolong
Amendment 42 #
Proposal for a regulation Recital 12 Amendment 43 #
Proposal for a regulation Recital 12 a (new) Amendment 44 #
Proposal for a regulation Recital 13 (13) The European Data Protection Supervisor and the European Data Protection Board were consulted in accordance with Article 42 of Regulation (EU) 2018/1725 and delivered a joint opinion on
Amendment 45 #
Proposal for a regulation Article 1 – paragraph 1 – point 1 Regulation (EU) 2021/953 Article 2 – paragraph 5 – point b a (new) (ba) antibody detection tests, including serological tests for SARS-CoV-2 antibodies, carried out by authorised personnel,
Amendment 46 #
Proposal for a regulation Article 1 – paragraph 1 – point 2 – point a – point i Regulation (EU) 2021/953 Article 3 – paragraph 1 – point b (b) a certificate confirming that the holder has been subject to a NAAT test,
Amendment 47 #
Proposal for a regulation Article premier – paragraph 1 – point 2 – point a – point i Regulation (EU) 2021/953 Article 3 – paragraph 1 – point b (b) a certificate confirming that the holder has been subject to a NAAT test, or an antigen test listed in the EU common list of COVID-19 antigen tests agreed by the Health Security Committee, or an immunological test showing the presence of antibodies, carried out by health professionals or by skilled testing personnel in the Member State issuing the certificate and indicating the type of test, the date on which it was carried out and the result of the test (test certificate);
Amendment 48 #
Proposal for a regulation Article 1 – paragraph 1 – point 2 – point a a (new) Regulation (EU) 2021/953 Article 3 – paragraph 1 – point b a (new) (ba) In paragraph 1, point (ba) is added: “(ba) antibody tests, including serological tests for antibodies against SARS-CoV-2, conducted by authorised personnel;”
Amendment 49 #
Proposal for a regulation Article 1 – paragraph 1 – point 2 – point a – point i a (new) Regulation (EU) 2021/953 (ia) point (c) is replaced by the following: (c) a certificate confirming that, following a positive result of a NAAT test, or a rapid antigen test listed in the EU common list of COVID-19 antigen tests agreed by the Health Security Committee, or an antibody test listed in the EU common list of COVID-19 antibody tests agreed by the Health Security Committee, carried out by health professionals or by skilled testing personnel, the holder has recovered from a SARS-CoV-2 infection (certificate of recovery).
Amendment 50 #
Proposal for a regulation Article 1 – paragraph 1 – point 2 – point a – point ii Regulation (EU) 2021/953 Article 3 – paragraph 1 – subparagraph 2 The Commission shall publish the EU common list of COVID-19 antigen tests and antibody tests, including serological tests for antibodies against SARS-CoV-2, agreed by the Health Security Committee, including any updates
Amendment 51 #
Proposal for a regulation Article 1 – paragraph 1 – point 2 a (new) Regulation (EU) 2021/953 Article 4 – paragraph 2 (2a) in Article 4, paragraph 2 is replaced by the following: “2. The trust framework shall be based on a public key infrastructure and allow for the reliable and secure issuance and verification of the authenticity, validity and integrity of the certificates referred to in Article 3(1). The trust framework shall allow for the detection of fraud, in particular forgery. In addition, it
Amendment 52 #
Proposal for a regulation Article 1 – paragraph 1 – point 3 – point a Regulation (EU) 2021/953 Article 5 – paragraph 2 – point b (b) information about the COVID
Amendment 53 #
Proposal for a regulation Article 1 – paragraph 1 – point 3 – point b Regulation (EU) 2021/953 Article 5 – paragraph 5 – subparagraph 3 a (new) Member States may also issue vaccination certificates referred to in point (a) of Article 3(1) to persons participating in clinical trials that concern a COVID-19 vaccine and that have been approved by Member States’ ethical committees and competent authorities, regardless whether they have been administered the vaccine candidate or the dose administered to the control group. The information about the COVID-19 vaccine to be included in the vaccination certificate in accordance with the specific data fields set out in point 1 of the Annex shall not undermine the integrity of the clinical trial.
Amendment 54 #
Proposal for a regulation Article 1 – paragraph 1 – point 3 – point b Regulation (EU) 2021/953 Article 5 – paragraph 5 – subparagraph 3 a (new) Member States may also issue vaccination certificates referred to in point (a) of Article 3(1) to persons participating in clinical trials that concern a COVID-19 vaccine and that have been approved by Member States’ ethical committees and competent authorities, regardless whether they have been administered the vaccine candidate or the dose administered to the control group. The information about the COVID-19 vaccine to be included in the vaccination certificate in accordance with the specific data fields set out in point 1 of the Annex shall not undermine the integrity of the clinical trial.
Amendment 55 #
Proposal for a regulation Article 1 – paragraph 1 – point 3 – point b Regulation (EU) 2021/953 Article 5 – paragraph 5 – subparagraph 3 a (new) Member States may also issue vaccination certificates referred to in point (a) of Article 3(1) to persons participating in clinical trials that concern a COVID-19 vaccine and that have been approved by Member States’ ethical committees and competent authorities, regardless whether they have been administered the vaccine candidate or the dose administered to the control group. The information about the COVID-19 vaccine to be included in the vaccination certificate in accordance with the specific data fields set out in point 1 of the Annex shall not undermine the integrity of the clinical trial. The validity period of such vaccination certificates shall not be longer than that of other vaccination certificates issued pursuant to this paragraph. Member States may accept vaccination certificates issued by other Member States in accordance with
Amendment 56 #
Proposal for a regulation Article 1 – paragraph 1 – point 3 – point b Regulation (EU) 2021/953 Article 5 – paragraph 5 – subparagraph 3 a (new) Member States may also issue vaccination certificates referred to in point (a) of Article 3(1) to persons participating in clinical trials that concern a COVID-19 vaccine and that have been approved by Member States’ ethical committees and competent authorities, regardless whether they have been administered the vaccine candidate or the dose administered to the control group. The information about the COVID-19 vaccine to be included in the vaccination certificate in accordance with the specific data fields set out in point 1 of
Amendment 57 #
Proposal for a regulation Article 1 – paragraph 1 – point 3 – point b Regulation (EU) 2021/593 Article 5 – paragraph 5 – subparagraph 3 a (new) Member States
Amendment 58 #
Proposal for a regulation Article 1 – paragraph 1 – point 3 – point b a (new) Regulation (EU) 2021/953 Article 5 – paragraph 5 – subparagraph 3 b (new) (ba) in paragraph 5, the following subparagraph is added: “By derogation from the second subparagraph, Member States shall accept vaccination certificates issued by other Member States in accordance with this Regulation for a COVID-19 vaccine which has been temporarily authorised pursuant to Article 5(2) of Directive 2001/83/EC if the vaccine was administered before 31 December 2021 and has been followed by a booster COVID-19 vaccine that has been granted a marketing authorisation pursuant to Regulation (EC) No 726/2004.”;
Amendment 59 #
Proposal for a regulation Article 1 – paragraph 1 – point 4 – point a (new) Regulation (EU) 2021/953 Article 6 – paragraph 2 – point b a (new) (a) in Article 6(2), the following point (ba) is added: “(ba) antibody tests, including serological tests for antibodies against SARS-CoV-2, carried out by authorised personnel”;
Amendment 60 #
Proposal for a regulation Article 1 – paragraph 1 – point 5 – point –a (new) Regulation (EU) 2021/953 Article 7 – paragraph 1 (-a) In Article 7, paragraph 1 is replaced by the following: "1. Each Member State shall issue, upon request, certificates of recovery referred to in point (c) of Article 3(1) following a positive result of a NAAT test carried out by health professionals or by skilled testing personnel. A Member State may also issue, upon request, certificates of recovery referred to in point (c) of Article 3(1) following a positive result of a rapid antigen test listed in the EU common list of COVID-19 antigen tests agreed by the Health Security Committee carried out by health professionals or by skilled testing personnel. Member States may issue certificates of recovery based on rapid antigen tests carried out by health professionals or by skilled testing personnel on or after 1 October 2021, provided that the rapid antigen test used was included in the EU common list of COVID-19 antigen tests agreed by the Health Security Committee at the time the positive test result was produced.
Amendment 61 #
Proposal for a regulation Article 1 – paragraph 1 – point 5 – point –a a (new) Regulation (EU) 2021/953 Article 7 – paragraph 1 (-aa) Article 7, paragraph (1) is replaced by the following: “(1) Each Member State shall issue, upon request, certificates of recovery
Amendment 62 #
Proposal for a regulation Article 1 – paragraph 1 – point 5 Regulation (EU) 2021/953 Article 7 – paragraph 4 Amendment 63 #
(4) On the basis of guidance received pursuant to Article 3(11), the Commission is empowered to adopt delegated acts in accordance with Article 12 to amend paragraph 1 of this Article and point (c) of Article 3(1) to allow for the issuance of the certificate of recovery on the basis of a positive antigen test, antibody test, including a serological test for antibodies against SARS-CoV-2, or any other scientifically validated method, so that holders of medical laboratory results can show that they have natural immunity or have recovered from the illness, and, consequently, the recovery certificates shall be valid indefinitely. Such delegated acts shall also amend point 3 of the Annex by adding, modifying or removing the data fields falling under the categories of personal data referred to in points (b) and (c) of paragraph 2 of this Article.
Amendment 64 #
Proposal for a regulation Article 1 – paragraph 1 – point 5 Regulation (EU) 2021/953 Article 7 – paragraph 4 4. On the basis of guidance received pursuant to Article 3(11), recommendations by the ECDC and where relevant other Union agencies, based on the latest scientific evidence, the Commission is empowered to adopt delegated acts in accordance with Article 12 to amend paragraph 1 of this Article and point (c) of Article 3(1) to allow for the issuance of the
Amendment 65 #
Proposal for a regulation Article 1 – paragraph 1 – point 5 a (new) Regulation (EU) 2021/953 Article 10 – paragraph 5 (5a) in Article 10, paragraph 5 is replaced by the following: “5. Any certificate revocation lists exchanged
Amendment 66 #
Proposal for a regulation Article 1 – paragraph 1 – point 5 b (new) Regulation (EU) 2021/953 Article 11 (5b) Article 11 is replaced by the following: “Article 11 Restrictions to free movement and information exchange 1. Without prejudice to Member States’ exclusive competence to impose restrictions to free movement on grounds of public health,
Amendment 67 #
Proposal for a regulation Article 1 – paragraph 1 – point 5 c (new) Regulation (EU) 2021/953 Article 11 (5c) Article 11
Amendment 68 #
Proposal for a regulation Article 1 – paragraph 1 – point 5 d (new) Regulation (EU) 2021/953 Article 11 – paragraph 4 a (new) (5d) In Article 11, the following paragraph is added: “4a. Member States shall not make use of the EU Digital COVID Certificate as a tool to implement domestic restrictions.”;
Amendment 69 #
Proposal for a regulation Article 1 – paragraph 1 – point 5 b (new) (5b) Article 11a is added: “Article 11a Use of the European Digital COVID certificate for domestic measures Where a Member State requires the use of COVID-19 certificates for domestic measures, it shall ensure that certificates making up the EU Digital COVID Certificate can also be used and are also accepted. Member States shall only adopt such domestic measures on the basis of the European COVID Barometer.”;
Amendment 70 #
Proposal for a regulation Article 1 – paragraph 1 – point 6 Regulation (EU) 2021/953 Article 12 – paragraph 2 Amendment 71 #
Proposal for a regulation Article 1 – paragraph 1 – point 6 Regulation (EU) 2021/953 Article 12 – paragraph 2 Amendment 72 #
Proposal for a regulation Article 1 – paragraph 1 – point 7 a (new) Regulation (EU) 2021/953 Article 16 (7a) Article 16 is replaced by the following: “Article 16 Commission report 1. By 31
Amendment 73 #
Proposal for a regulation Article 1 – paragraph 1 – point 7 b (new) Regulation (EU) 2021/953 Article 16 (7b) Article 16
Amendment 74 #
Proposal for a regulation Article 1 – paragraph 1 – point 7 c (new) Regulation (EU) 2021/953 Article 16 (7c) Article 16
Amendment 75 #
Proposal for a regulation Article 1 – paragraph 1 – point 7 d (new) Regulation (EU) 2021/953 Article 16 – paragraph 2 (7d) In Article 16, paragraph 2 is replaced by the following: "2. By 31
Amendment 76 #
Proposal for a regulation Article 1 – paragraph 1 – point 7 e (new) Regulation (EU) 2021/953 Article 16 – paragraph 3 (new) Amendment 77 #
Proposal for a regulation Article 1 – paragraph 1 – point 8 Regulation (EU) 2021/953 Article 17 – paragraph 2 Amendment 78 #
Proposal for a regulation Article 1 – paragraph 1 – point 8 Regulation (EU) 2021/953 Article 17 – paragraph 2 It shall apply from 1 July 2021 to 30 June 2023
Amendment 79 #
Proposal for a regulation Article 1 – paragraph 1 – point 8 Regulation (EU) 2021/593 Article 17 – paragraph 2 It shall apply from 1 July 2021 to 30 June 2023, or until the WHO has declared that the COVID-19 pandemic has ended, whichever is earlier.;
Amendment 80 #
Proposal for a regulation Article 1 – paragraph 1 – point 8 Regulation (EU) 2021/953 Article 17 – paragraph 2 It shall apply from 1 July 2021 to 30 June 2023, without prejudice to Article 16.;
Amendment 81 #
Proposal for a regulation Article 1 – paragraph 1 – point 8 Regulation (EU) 2021/953 Article 17 – paragraph 2 It shall apply from 1 July 2021 to
Amendment 82 #
Proposal for a regulation Article premier – paragraph 1 – point 8 Regulation (EU) 2021/953 Article 17 – paragraph 2 It shall apply from 1 July 2021 to 30 June 202
Amendment 83 #
Proposal for a regulation Article 1 – paragraph 1 – point 8 Regulation (EU) 2021/953 Article 17 – paragraph 2 It shall apply from 1 July 2021 to 30 June 202
Amendment 84 #
Proposal for a regulation Article 1 – paragraph 1 – point 9 Regulation (EU) 2021/953 Annex – point 2 – point i (i) testing centre or facility (optional
Amendment 85 #
Proposal for a regulation Article 3 – paragraph 1 This Regulation shall
source: 731.523
|
History
(these mark the time of scraping, not the official date of the change)
2022-05-30Show (1) Changes | Timetravel
| forecasts |
|
2022-05-22Show (2) Changes | Timetravel
| docs/0 |
|
| docs/0 |
|
2022-05-16Show (4) Changes | Timetravel
| docs/3 |
|
| procedure/dossier_of_the_committee |
|
| procedure/legal_basis |
|
| procedure/stage_reached |
Old
Awaiting committee decisionNew
Awaiting Parliament's position in 1st reading |
2022-04-27Show (1) Changes | Timetravel
| docs/3/docs/0/url |
https://www.europarl.europa.eu/doceo/document/LIBE-AM-731523_EN.html
|
2022-04-08Show (1) Changes | Timetravel
| docs/3 |
|
2022-04-06Show (1) Changes | Timetravel
| docs/2/docs/0/url |
https://www.europarl.europa.eu/doceo/document/ENVI-AD-730193_EN.html
|
2022-04-05Show (1) Changes | Timetravel
| docs/2/date |
Old
2022-04-04T00:00:00New
2022-04-05T00:00:00 |
2022-04-04Show (1) Changes | Timetravel
| docs/2 |
|
2022-04-01Show (2) Changes | Timetravel
| committees/0 |
|
| committees/0 |
|
2022-03-24Show (1) Changes | Timetravel
| docs/2 |
|
2022-03-23Show (1) Changes | Timetravel
| docs/1/docs/0/url |
https://www.europarl.europa.eu/doceo/document/LIBE-PR-729924_EN.html
|
2022-03-22Show (4) Changes | Timetravel
| committees/1/rapporteur |
|
| docs/1 |
|
| docs/2 |
|
| docs/2/date |
Old
2022-03-17T00:00:00New
2022-03-21T00:00:00 |
2022-03-19Show (2) Changes | Timetravel
| docs/1 |
|
| docs/2 |
|
2022-03-17Show (2) Changes | Timetravel
| committees/0 |
|
| committees/0 |
|
2022-03-15Show (1) Changes | Timetravel
| committees/2/rapporteur |
|
2022-03-02Show (1) Changes | Timetravel
| committees/2 |
|
2022-02-18Show (4) Changes
| docs/0/summary |
|
| events |
|
| procedure/dossier_of_the_committee |
|
| procedure/stage_reached |
Old
Preparatory phase in ParliamentNew
Awaiting committee decision |